Absorica Ld Capsule
Product Images NDC 10631-003

21 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Absorica Ld (NDC 10631-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Total Nodular (facial And Truncal)1 (Graph1)

Total Nodular (facial And Truncal)1 (Graph1)
A line graph comparing mean lesion count over time between Absorica and Isotretinoin. The x-axis shows analysis visits from baseline through week 20, and the y-axis shows mean lesion count. Both lines decrease similarly over the weeks, with Absorica represented by a solid blue line with circles and Isotretinoin by a dashed gray line with diamonds.*
FDA Label Image

Absorica-10mg-blister (Absorica 10mg Blister)

Absorica-10mg-blister (Absorica 10mg Blister)
Absorica LD 10 mg soft gelatin capsules packaging label by Sun Pharmaceutical Industries, Inc. The label includes warnings for female patients about serious birth defects and instructions not to get pregnant while using this medication. It details precautions, adverse effects, patient responsibilities, and storage instructions. The packaging shows a carton layout with blister card designs for multiple capsules, barcode, and regulatory references.*
FDA Label Image

Absorica-carton-10mg (Absorica Carton 10mg)

Absorica-carton-10mg (Absorica Carton 10mg)
Absorica LD 10 mg capsules packaging label showing that each capsule contains 10 mg isotretinoin. The label includes dosage form as capsules, package size of 30 capsules (3 x 10 prescription packs), and the labeler Sun Pharmaceutical Industries, Inc. It also features warnings including contraindication in pregnancy and instructions for pharmacists and patients. The product is designated Rx only.*
FDA Label Image

Absorica-20mg-blister (Absorica 20mg Blister)

Absorica-20mg-blister (Absorica 20mg Blister)
This image is a multi-panel drug safety information leaflet for Absorica LD, available from Sun Pharmaceutical Industries. It highlights serious birth defect risks associated with use in female patients, warnings about pregnancy, instructions to avoid pregnancy during treatment, and signs of depression or psychosis requiring medical attention. It includes a visual warning layout for dispensing blister packs and emphasizes patient counseling regarding birth defect risks and mental health monitoring.*
FDA Label Image

Absorica-20mg-carton (Absorica 20mg Carton)

Absorica-20mg-carton (Absorica 20mg Carton)
Absorica LD 20 mg (isotretinoin) capsules packaging label. The label indicates 20 mg strength with 30 capsules per carton, intended for prescription use only. The box includes storage instructions, warnings about use during pregnancy, and pharmacy dispensing information. Manufactured by Sun Pharmaceutical Industries, Inc.*
FDA Label Image

Absorica-25mg-blister (Absorica 25mg Blister)

Absorica-25mg-blister (Absorica 25mg Blister)
Absorica LD 25 mg packaging insert panels containing detailed warnings and important information. The text emphasizes serious birth defects risk in female patients, instructions to not get pregnant, and detailed special warnings including mental health side effects. Illustrations demonstrate pregnancy prevention steps, tablet dispensing diagrams, and medication handling precautions. The labeler is Sun Pharmaceutical Industries, Inc.*
FDA Label Image

Absorica-25mg-carton (Absorica 25mg Carton)

Absorica-25mg-carton (Absorica 25mg Carton)
Packaging label for Absorica 25 mg capsules by Sun Pharmaceutical Industries, Inc. The label indicates isotretinoin capsules, with each capsule containing 25 mg isotretinoin USP. The package includes warnings about use in pregnancy and special storage instructions. It states the package contains 30 capsules and emphasizes these are Rx-only prescription packs.*
FDA Label Image

Absorica-30mg-blister (Absorica 30mg Blister)

Absorica-30mg-blister (Absorica 30mg Blister)
The image contains detailed patient safety information for Absorica LD, highlighting serious birth defect risks for female patients and strict pregnancy prevention requirements. It includes warnings about depression and suicidal thoughts, instructions for female patients about pregnancy testing and contraception, and diagrams illustrating proper pill dispenser use and warnings against pregnancy while using Absorica.*
FDA Label Image

Absorica-30mg-carton (Absorica 30mg Carton)

Absorica-30mg-carton (Absorica 30mg Carton)
Packaging label for Absorica 30 mg (isotretinoin) capsules by Sun Pharmaceutical Industries, Inc. The label states each capsule contains 30 mg of isotretinoin, USP, with 30 capsules per bottle in 10 prescription packs. It includes warnings about pregnancy contraindication and pharmacist instructions, and storage conditions specifying protection from light and control of temperature between 15°C to 30°C (59°F to 86°F).*
FDA Label Image

Absorica-35mg-blister (Absorica 35mg Blister)

Absorica-35mg-blister (Absorica 35mg Blister)
This image shows patient warning and safety information for Absorica LD, a medication by Sun Pharmaceutical Industries, Inc. It includes serious birth defect warnings for females, special warnings for female patients, and symptoms of depression or psychosis. Illustrations depict fetal development stages and the medication's packaging with clear pregnancy caution symbols.*
FDA Label Image

Absorica-35mg-carton (Absorica 35mg Carton)

Absorica-35mg-carton (Absorica 35mg Carton)
Packaging label for Absorica LD (isotretinoin) capsules, 35 mg strength. The label includes dosage and storage instructions, warnings regarding pregnancy contraindications, and pharmacist attention advice. The product is labeled for dispensing prescription packs intact, contains 30 capsules (3 x 10 capsule packs), and is manufactured by Sun Pharmaceutical Industries, Inc.*
FDA Label Image

Absorica-40mg-blister (Absorica 40mg Blister)

Absorica-40mg-blister (Absorica 40mg Blister)
The image shows detailed medication guide text panels for Absorica LD in multiple strengths. It includes warnings about serious birth defects, special warnings for female patients, instructions to avoid pregnancy, and lists of symptoms of depression or psychosis requiring medical attention. The panels also show blister pack diagrams and emphasize that female patients must not get pregnant while using Absorica LD. The labeler is Sun Pharmaceutical Industries, Inc.*
FDA Label Image

Absorica-40mg-carton (Absorica 40mg Carton)

Absorica-40mg-carton (Absorica 40mg Carton)
Absorica LD 40 mg capsules carton label from Sun Pharmaceutical Industries, Inc. The label indicates each capsule contains 40 mg of isotretinoin available in a package of 30 capsules (in 30 prescription packs). Storage instructions specify temperature control and protection from light. There is a pregnancy warning and a pharmacist dispensing note on the carton.*
FDA Label Image

Absoricald-8mg-blister (Absoricald 8mg Blister)

Absoricald-8mg-blister (Absoricald 8mg Blister)
Absorica LD 8 mg capsules by Sun Pharmaceutical Industries, Inc. This carton and blister packaging displays the 8 mg soft gelatin capsules along with multiple patient safety warnings. Important highlights include the severe birth defect warnings for female patients, instructions on proper use, and precautions against pregnancy during treatment. The packaging shows both the outer box and blister card layout with 14 capsules visible.*
FDA Label Image

Absoricald-8mg-carton (Absoricald 8mg Carton)

Absoricald-8mg-carton (Absoricald 8mg Carton)
Absorica LD 8 mg capsules packaging label from Sun Pharmaceutical Industries, Inc. The label displays the proprietary name Absorica LD with the active ingredient isotretinoin. It indicates that each capsule contains 8 mg isotretinoin and the package contains 30 capsules (3 x 10 prescription packs). The label includes dosage information, contraindications for pregnancy, and handling instructions with warnings to protect from light and keep out of reach of children. The label also features barcodes, manufacturer details, and instructions for pharmacists regarding prescription dispensing and storage.*
FDA Label Image

Absoricald-16mg-blister (Absoricald 16mg Blister)

Absoricald-16mg-blister (Absoricald 16mg Blister)
Absorica LD film-coated capsules are shown in a detailed packaging label layout including blister card images and extensive female patient warnings about birth defects. The label set covers strengths including 8 mg, 10 mg, 16 mg, 20 mg, 24 mg, 25 mg, 30 mg, 32 mg, 35 mg, and 40 mg, provided by Sun Pharmaceutical Industries, Inc. The label emphasizes careful patient education, pregnancy prevention, and usage instructions for this isotretinoin product.*
FDA Label Image

Absoricald-16mg-carton (Absoricald 16mg Carton)

Absoricald-16mg-carton (Absoricald 16mg Carton)
Packaging label for Absorica LD 16 mg capsules, USP by Sun Pharmaceutical Industries, Inc. The label includes the proprietary name, active ingredient isotretinoin, strength 16 mg per capsule, and quantity of 30 capsules (3 x 10 prescription packs). The label features usage warnings, storage instructions, pharmacist directions, and barcode area.*
FDA Label Image

Absoricald-24mg-blister (Absoricald 24mg Blister)

Absoricald-24mg-blister (Absoricald 24mg Blister)
Absorica LD oral capsules label from Sun Pharmaceutical Industries, Inc. The label includes warnings about risks for female patients, especially concerning birth defects and pregnancy prevention measures. It displays multiple capsule images indicating various strengths from 8 mg to 40 mg, dosage instructions, and safety information emphasizing the importance of avoiding pregnancy during treatment. The label is intended for prescription use and provides detailed patient safety warnings.*
FDA Label Image

Absoricald-24mg-carton (Absoricald 24mg Carton)

Absoricald-24mg-carton (Absoricald 24mg Carton)
Packaging label for Absorica LD 24 mg capsules, USP by Sun Pharmaceutical Industries, Inc. The box contains 30 capsules (3 x 10 prescription packs). The label highlights the active ingredient isotretinoin per capsule and includes warnings about prescription status and pregnancy contraindications. The design features purple and green text with dosage strength in large font on a white background.*
FDA Label Image

Absorica-ld-32mg-blister (Absorica Ld 32mg Blister)

Absorica-ld-32mg-blister (Absorica Ld 32mg Blister)
Absorica LD packaging label showing tablet blister layout and detailed patient warnings. The label features the proprietary name Absorica LD by Sun Pharmaceutical Industries, Inc., with multiple strength references from 8 mg to 40 mg. Prominent warnings for female patients about severe birth defects and pregnancy precautions are visible. The label includes barcode, lot information, and extensive safety instructions with illustrative diagrams.*
FDA Label Image

Absoricald-32mg-carton (Absoricald 32mg Carton)

Absoricald-32mg-carton (Absoricald 32mg Carton)
Absorica LD 32 mg capsules, containing isotretinoin, in a package label from Sun Pharmaceutical Industries, Inc. The label indicates 30 capsules (3 packs of 10), prescription only, with warnings about pregnancy and pharmacist instructions. The label includes dosage strength, storage instructions, and barcode details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.